Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amboy Street Ventures has closed its debut $20 million fund and invested in at least eight early-stage startups focused on women’s health and sexual wellbeing. The firm has already seen its first exit with Gennev being acquired by Unified Women’s Healthcare. Its portfolio includes innovative solutions across vaginal microbiome testing (Evvy), non-hormonal male birth control (Contraline), menopause relief (Alloy), at-home insemination kits (Bea Fertility), telehealth abortion access (Hey Jane), at-home STI testing (Testmate), IVF medication development/commercialization platforms (Granata Bio), menstrual product distribution systems for public spaces (Aunt Flow) and more.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amboy Street Ventures.